ZEB1 and breast carcinoma: Importantly, our study introduced the potential therapeutic approaches that disrupt the link between Zeb1-induced aerobic glycolysis and carcinogenesis, eventually leading to improvement of the clinical outcomes of patients with aggressive breast cancer.